Capillect

Company Overview

Snapshot

Founded in January 2016 by Aviv Peleg, Roi Klein, Shlomi Dach, and Fadi Shiban, Capillect operates with 1–10 employees. The company is currently in a Pre-Funding stage.

Business overview

Capillect is developing a minimally invasive blood collection device designed to integrate into existing blood sampling workflows. The company's core technology utilizes a proprietary flow intensifying mechanism to provide a simple, safe, and nearly painless blood sampling procedure for both healthcare professionals and consumers. Capillect operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices, and serves markets including healthcare providers, patients, and general consumers.

Company Intelligence Q&A

What is Capillect's primary focus?

Capillect is focused on developing a minimally invasive blood collection device. This device is designed to improve current blood sampling procedures.

When was Capillect founded?

Capillect was founded in January 2016.

Who are the founders of Capillect?

Capillect was founded by Aviv Peleg, Roi Klein, Shlomi Dach, and Fadi Shiban.

What is the current employee size of Capillect?

Capillect currently has 1–10 employees.

What markets does Capillect target?

Capillect targets the healthcare and life sciences markets, serving healthcare providers, patients, and consumers with its medical device technology.